The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinase
Cyclooxygenase (COX), existing as the COX-1 and COX-2 isoforms, converts arachidonic acid to prostaglandin H2, which is then further metabolized to various prostaglandins. Vascular endothelial growth factor (VEGF) has been shown to play important roles in inflammation and is upregulated by the prost...
Saved in:
| Main Authors: | Pravit Akarasereenont, Kitirat Techatraisak, Athiwat Thaworn, Sirikul Chotewuttakorn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2002-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1080/09629350210311 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Food interactions with tyrosine kinase inhibitors used to treat advanced renal cell carcinoma
by: Agata Sałek-Zań, et al.
Published: (2025-03-01) -
Expression of arginase 1 and tyrosine kinase Mer by blood monocytes in the dynamics of physiological pregnancy
by: E. Ya. Shevela, et al.
Published: (2023-06-01) -
Protein kinase C and endothelial dysfunction in select vascular diseases
by: Shawn Kant, et al.
Published: (2025-08-01) -
A pharmacovigilance study of thromboembolism events associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors based on FAERS database
by: Zongwei Tang, et al.
Published: (2025-07-01) -
Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder.
by: Young H Lee, et al.
Published: (2021-01-01)